An overview of potential molecular mechanisms involved in VSMC phenotypic modulation

被引:84
作者
Zhang, Ming-Jie [1 ]
Zhou, Yi [1 ]
Chen, Lei [1 ]
Wang, Yan-Qin [2 ]
Wang, Xu [1 ]
Pi, Yan [1 ]
Gao, Chang-Yue [1 ]
Li, Jing-Cheng [1 ]
Zhang, Li-Li [1 ]
机构
[1] Third Mil Med Univ, Dept Neurol, Inst Surg Res, Daping Hosp, 10 Changjiang Branch Rd, Chongqing 400042, Peoples R China
[2] Zibo Mil Subarea, Retired Cadres Clin 1, Zibo 255000, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Vascular smooth muscle cells; Phenotypic modulation; Molecular mechanisms; MicroRNAs; Ion channels; VASCULAR SMOOTH-MUSCLE; GROWTH-FACTOR RECEPTOR; CELL-PROLIFERATION; DOWN-REGULATION; CONTRACTILE PHENOTYPE; SIGNALING PATHWAYS; NEOINTIMAL FORMATION; MEDIATED REGULATION; GENE-EXPRESSION; CONTROL ELEMENT;
D O I
10.1007/s00418-015-1386-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The fully differentiated medial vascular smooth muscle cells (VSMCs) of mature vessels keep quiescent and contractile. However, VSMC can exhibit the plasticity in phenotype switching from a differentiated and contractile phenotype to a dedifferentiated state in response to alterations in local environmental cues, which is called phenotypic modulation or switching. Distinguishing from its differentiated state expressing more smooth muscle (SM)-specific/selective proteins, the phenotypic modulation in VSMC is characterized by an increased rate of proliferation, migration, synthesis of extracellular matrix proteins and decreased expression of SM contractile proteins. Although it has been well demonstrated that phenotypic modulation of VSMC contributes to the occurrence and progression of many proliferative vascular diseases, little is known about the details of the molecular mechanisms of VSMC phenotypic modulation. Growing evidence suggests that variety of molecules including microRNAs, cytokines and biochemical factors, membrane receptors, ion channels, cytoskeleton and extracellular matrix play important roles in controlling VSMC phenotype. The focus of the present review is to provide an overview of potential molecular mechanisms involved in VSMC phenotypic modulation in recent years. To clarify VSMC differentiation and phenotypic modulation mechanisms will contribute to producing cell-based therapeutic interventions for aberrant VSMC differentiation-related diseases.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 50 条
  • [31] Rapamycin Treatment Attenuates Angiotensin Ⅱ-induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity
    李飞飞
    尚小珂
    杜心灵
    陈澍
    Current Medical Science, 2018, (01) : 93 - 100
  • [32] Signaling pathways involved in paraquat-induced pulmonary toxicity: Molecular mechanisms and potential therapeutic drugs
    Liu, Xianbo
    Yang, He
    Liu, Zhenning
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [33] Cell death modulation by transient receptor potential melastatin channels TRPM2 and TRPM7 and their underlying molecular mechanisms
    Shi, Ruixue
    Fu, Yu
    Zhao, Dongyi
    Boczek, Tomasz
    Wang, Wuyang
    Guo, Feng
    BIOCHEMICAL PHARMACOLOGY, 2021, 190
  • [34] Cellular and Molecular Mechanisms of Phenotypic Switch in Gastrointestinal Smooth Muscle
    Scirocco, Annunziata
    Matarrese, Paola
    Carabotti, Marilia
    Ascione, Barbara
    Malorni, Walter
    Severi, Carola
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (02) : 295 - 302
  • [35] Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts
    Naot, Dorit
    Chhana, Ashika
    Matthews, Brya G.
    Callon, Karen E.
    Tong, Pak C.
    Lin, Jian-Ming
    Costa, Jessica L.
    Watson, Maureen
    Grey, Andrew B.
    Cornish, Jillian
    BONE, 2011, 49 (02) : 217 - 224
  • [37] Molecular Mechanisms Involved in the Control of Neurohypophyseal Hormones Secretion
    Iovino, M.
    Guastamacchia, E.
    Giagulli, V. A.
    Licchelli, B.
    Iovino, E.
    Triggiani, V.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (42) : 6702 - 6713
  • [38] Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids
    GoppeltStruebe, M
    BIOCHEMICAL PHARMACOLOGY, 1997, 53 (10) : 1389 - 1395
  • [39] Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms
    Sheida, Amirhossein
    Farshadi, Marjan
    Mirzaei, Amirhossein
    Khalilabad, Shakiba Najjar
    Zarepour, Fatemeh
    Taghavi, Seyed Pouya
    Khabr, Maryam Sadat Hosseini
    Ravaei, Fatemeh
    Rafiei, Sara
    Mosadeghi, Kimia
    Yazdani, Mohammad Sepehr
    Fakhraie, Ali
    Ghattan, Alireza
    Fard, Mohammad Masoud Zamani
    Shahyan, Maryam
    Rafiei, Moein
    Rahimian, Neda
    Zavareh, Sayyed Alireza Talaei
    Mirzaei, Hamed
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, : 3157 - 3208
  • [40] Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity
    Fei-fei Li
    Xiao-ke Shang
    Xin-ling Du
    Shu Chen
    Current Medical Science, 2018, 38 : 93 - 100